MCLA-128 With Trastuzumab/Chemotherapy in HER2+ and With Endocrine Therapy in ER+ and Low HER2 Breast Cancer.

Clinical trial NCT03321981 · COMPLETED

Trial details

NCT number: NCT03321981
Sponsor: Merus B.V.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Metastatic

Start date: 2018-01-15
Primary completion: 2022-10-26
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.